William McCorkle - 18 Feb 2025 Form 4 Insider Report for CV Sciences, Inc. (CVSI)

Reporting relationship: Director
Issuer ticker: CVSI
Reported as of: 18 Feb 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 20 Feb 2025, 17:27:07 UTC
Prior SEC filing: 24 Jun 2024
Source filing: View source filing
Reporting owner signature: /s/ Joerg Grasser as attorney-in-fact for William McCorkle

Key filing fact

William McCorkle filed Form 4 for CV Sciences, Inc. (CVSI) on 20 Feb 2025.

Key facts

This page summarizes William McCorkle's Form 4 filing for CV Sciences, Inc. (CVSI).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 20 Feb 2025, 17:27.

Change

Previous filing in this sequence was filed on 24 Jun 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CVSI transaction Derivative

Stock Optoin (right to buy)

Award

Transaction value: $0
Shares: +500,000
Change %
Price: $0.000000
Shares after: 500,000
Date: 18 Feb 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 500,000
Exercise price: $0.0373
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option is durational-based. No option shares are vested on the date of grant. The option shares vest and become exercisable on April 30, 2026, provided, that there has not been a termination of service as of such date. In no event will any unvested portion of the option vest or become exercisable for any additional option shares after a termination of service.